Xuzhou Nova Medical Instrument Co., Ltd.

KJ-9000 Microwave Hyperthermia Equipment For Tumor

KJ-9000 Microwave Hyperthermia Equipment For Tumor
Product Detailed

Clinical application Chemotherapy assisted with microwave heat treatment can promote the effect of chemical agents 10-14 time.

Product Specification:

1. Temperature measurement installment: High-resistance noninterference real-time temperature measurement system, 25-50 degrees C the software calibrates automatically, high accuracy.

2. Radiator: the American Stanford University designs, highly effective, even heating field distribution.

3. Equipped with the overpower, owe power auto-alarm stop output function.

4. Equipped with the urgent, the manual dump, guarantees the security.

5. Electrical operate bed: 2000mmX650mm, load-carrying capacity 200Kg; The longitudinal adjustment scope is 420mm, the running rate 17mm/s.

6. C arm: The high and low adjustment scope is 240mm, running rate 4mm/s; Crosswise adjustment angle 120°.

7. Conforms to GB9706.1 and GB9706.6 the standard.

8. Working conditions: 60dB shield ability.

 

Range of indication:

 

Tumors: Tumors on body surface: breast cancer, skin cancer, caput and cervical metastatic carcinoma parenchyma sarcoma and so on.

Intracavity tumors: cervical carcinoma, esophagus cancer, etc.

 

Benign diseases: Disease in the department of gynecology and andriatrics: mastitis, pelvic inflammation, adnexitis, prostatitis, acute urethritis caused by gonococcus and anal abscess.

Surgical diseases: Periarthritis, strain of lumbar muscles, sciatica, inflammation of surgical incision.

Other disease: derma eczema, zona, neuritis, rheumatism and rheumatoid arthritis and so on.

 

Proved by:

 

1.Clinical application Chemotherapy assisted with microwave heat treatment can promote the effect of chemical agents 10-14 time.

2.The the rapeutic effect of radiotheraphy can be increased notably when combined with microwave heat treatment.



Copyright Notice @ 2008-2021 B2BAGE Limited and/or its subsidiaries and licensors. All rights reserved.